Showing 10 posts of 10 posts found.


MannKind entices Lilly VP to CMO role

February 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …


New chief exec at MannKind

January 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer

The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …


Sanofi abandons MannKind’s failed inhalable insulin

January 6, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Afrezza, Mannkind, Sanofi, insulin

Sanofi is to exit a licensing and co-marketing deal with MannKind for the inhalable insulin Afrezza, after disappointing sales figures …

affrezza image

Sanofi’s inhalable insulin goes on sale in US

February 3, 2015
Sales and Marketing Afrezza, FDA, Mannkind, Sanofi, US, apidra, diabetes, insulin, type 1, type 2

Sanofi has launched its inhalable insulin Afrezza in the US to control blood sugar in people with type 1 and …

Affreza image

FDA ‘yes’ to inhaled insulin

June 30, 2014
Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human

The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …

Afrezza image

Inhaled insulin one step closer to approval

April 3, 2014
Sales and Marketing Afrezza, FDA, Mannkind, diabetes, type 1, type 2

After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …

Awards recognise top pharma manufacturing projects

January 19, 2010
Manufacturing and Production Biogen, Genentech, Mannkind, Pfizer

The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …

Manufacturing news in brief

January 12, 2010
Manufacturing and Production ACell, Cel-Sci, Dr Reddy's Laboratories, Genzyme, Mannkind, Pfizer, Transgene Biotek, Viva Pharmaceutical

This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …

Mannkind picks up Pfizer’s Exubera facility

March 16, 2009
Manufacturing and Production Mannkind, diabetes

The demise of Pfizer's inhaled diabetes treatment Exubera cast a pall over the prospects for inhaled insulin therapy, but has …

Latest content